2,6-Dichloropyrimidine-4-carbonitrile

Catalog No.: 
ACJPON389
CAS No.: 
26293-93-6
Molecular Formula: 
C5HCl2N3
Molecular Weight: 
173.99
2,6-Dichloropyrimidine-4-carbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$133.00In stockIn stock
25g98%$514.00In stockIn stock
100g98%$1678.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,6-Dichloropyrimidine-4-carbonitrile
IUPAC Name2,6-dichloropyrimidine-4-carbonitrile
MDL No.MFCD16988336
Molecular FormulaC5HCl2N3
Molecular Weight173.99
SMILESN#CC1=NC(Cl)=NC(Cl)=C1
InChI KeyHLAOENZTDMPYNY-UHFFFAOYSA-N
SynonymGS-6530 | SCHEMBL17608843 | 2,4-Dichloro-6-cyanopyrimidine | J-507458 | SY031875 | AMY22952 | CS-W019274 | FT-0722835 | 2,6-Dichloro-4-pyrimidinecarbonitrile | MFCD16988336 | AKOS015920217 | A877280 | 2,6-DICHLOROPYRIMIDINE-4-CARBONITRILE | SB57831 | 4-Py
CAS No.26293-93-6

Synthetic Route by SureRoute

1. ACJPON389 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWGBL204 route compound structure diagram
    ACWGBL20498136-42-6In Stock
  2. Then
  3. ACJPON389 route product structure diagram
    ACJPON38926293-93-6In Stock
Inquiry

2. ACJPON389 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACGWVT512 route compound structure diagram
    ACGWVT51298519-66-5In Stock
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1In Stock
  4. Then
  5. ACJPON389 route product structure diagram
    ACJPON38926293-93-6In Stock
Inquiry

3. ACJPON389 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKXJG657 route compound structure diagram
    ACKXJG6573764-01-0In Stock
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1In Stock
  4. Then
  5. ACJPON389 route product structure diagram
    ACJPON38926293-93-6In Stock
Inquiry

Comments (0)